Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oasmia Pharmaceutical AB | 27,258,428 | net | 22 Jan 2026 | tx 7+27,258,428 |
| HQ AB | 1,335,975 | net | 05 Dec 2017 | tx 5+1,335,975 |
| Bio-Works Technologies AB | 61,000 | net | 21 Jul 2021 | tx 1+61,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jan 2026 | PURCHASE | Oasmia Pharmaceutical AB | 859,940 | 0.11 SEK | |
| 22 Mar 2022 | PURCHASE | Oasmia Pharmaceutical AB | 120,000 | 1.68 SEK | |
| 21 Jul 2021 | PURCHASE | Bio-Works Technologies AB | 61,000 | 32.81 SEK | |
| 16 Jul 2021 | PURCHASE | Oasmia Pharmaceutical AB | 100,000 | 3.03 SEK | first after silence |
| 27 Nov 2019 | PURCHASE | Oasmia Pharmaceutical AB | 500,000 | 2.00 SEK | |
| 25 Nov 2019 | PURCHASE | Oasmia Pharmaceutical AB | 625,000 | 1.29 SEK | derivfirst after silence |
| 05 Jul 2019 | OTHER | Oasmia Pharmaceutical AB | 24,193,548 | 3.10 SEK | |
| 04 Dec 2017 | PURCHASE | HQ AB | 20,779 | 0.77 SEK | |
| 05 Dec 2017 | PURCHASE | HQ AB | 179,221 | 0.79 SEK | |
| 09 Aug 2017 | PURCHASE | HQ AB | 160,588 | 0.80 SEK | |
| 11 Aug 2017 | PURCHASE | HQ AB | 779,157 | 0.82 SEK | |
| 20 Jun 2017 | PURCHASE | HQ AB | 196,230 | 0.50 SEK |
2 purchases reported after at least 12 months of silence — most recent on 16 Jul 2021.